Nanomedicine News RSS Feed - Nanomedicine

DFG to Continue Support for Building Tiny Machine-Like Molecules

DFG to Continue Support for Building Tiny Machine-Like Molecules

Great excitement at Kiel University: As the DFG (German Research Foundation) announced today (Thursday, May 21), it will continue to support the research on molecules which function like machines with another 8.9 million EUR. This funding will allow the scientists in Germany's northernmost state to develop new engineering techniques for building tiny machine-like molecules over the next four years. [More]
Ultrasound-Guided Photoacoustics Combined with Nanosensors Identifies Metastatic Cells in Lymph Nodes

Ultrasound-Guided Photoacoustics Combined with Nanosensors Identifies Metastatic Cells in Lymph Nodes

NIBIB-funded researchers have developed a highly sensitive and accurate imaging technique for non-invasive screening of lymph nodes for metastatic cancer. Current practice calls for invasive surgical biopsies to determine whether deadly metastatic cancer cells have invaded the lymph nodes. [More]
Aura Biosciences’ AU-011 Granted Orphan Disease Designation by the FDA for Uveal Melanoma Treatment

Aura Biosciences’ AU-011 Granted Orphan Disease Designation by the FDA for Uveal Melanoma Treatment

Aura Biosciences, a biotech company developing highly tumor-targeted breakthrough therapies for rare cancers, has been granted Orphan Disease Designation by the FDA for its drug AU-011 for the treatment of Uveal Melanoma. [More]
Preclinical Study Confirms Safety of TheraSilence Technology Platform to Deliver RNA to the Lungs

Preclinical Study Confirms Safety of TheraSilence Technology Platform to Deliver RNA to the Lungs

Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies for the treatment of cancer and other difficult-to-treat diseases, today reported data from a preclinical study confirming that the Company's TheraSilence™ technology platform can safely and effectively deliver RNA to the lungs in non-human primates. [More]
Novel Nanoparticle-Based Therapy Effectively Treats Mice with Multiple Myeloma

Novel Nanoparticle-Based Therapy Effectively Treats Mice with Multiple Myeloma

Researchers have designed a nanoparticle-based therapy that is effective in treating mice with multiple myeloma, a cancer of immune cells in the bone marrow. [More]
NIH Awards Grant to Develop ‘Nanobombs’ to Treat Biofilm Infection in Chronic Wounds

NIH Awards Grant to Develop ‘Nanobombs’ to Treat Biofilm Infection in Chronic Wounds

The National Institutes of Health (NIH) has awarded Kent State University's Min-Ho Kim, Ph.D., assistant professor of biological sciences in the College of Arts and Sciences, a $1,842,350 five-year grant. The grant from the NIH's National Institute of Nursing Research is to develop "nanobombs," a nanotechnology-based therapeutic platform that can treat biofilm infection in chronic wounds. [More]
Mesoporous Particles Consisting Solely of Phospholipids for Drug Delivery

Mesoporous Particles Consisting Solely of Phospholipids for Drug Delivery

A research group at MANA, NIMS, succeeded in developing porous particles (mesoporous particles) consisting solely of phospholipids, a biological component, that are suitable for use as a drug delivery system. [More]
Functional Surfaces of Gold Nanoparticles Act on Osteogenic Differentiation of Stem Cells

Functional Surfaces of Gold Nanoparticles Act on Osteogenic Differentiation of Stem Cells

Tissue Regeneration Materials Unit at MANA, NIMS successfully developed gold nanoparticles that have functional surfaces and act on osteogenic differentiation of stem cells. [More]
Global Market for Nanoparticles in Biotechnology and Pharmaceuticals Expected to Reach $79.8 Billion in 2019

Global Market for Nanoparticles in Biotechnology and Pharmaceuticals Expected to Reach $79.8 Billion in 2019

This BCC Research report provides detailed product analyses within health and wellness subsegments to overall industry trends in order to quantify and qualify the market for drug products for treating various disease conditions in both men and women. The applicability of specific types of nanoparticles for specific applications is also discussed. CAGR projections are given from the period 2014 through 2019. [More]
Plasmons Influence Carbon-Based Nanoparticles for Sensitizing Cancerous Tumors

Plasmons Influence Carbon-Based Nanoparticles for Sensitizing Cancerous Tumors

Radiotherapy used in cancer treatment is a promising treatment method, albeit rather indiscriminate. Indeed, it affects neighbouring healthy tissues and tumours alike. Researchers have thus been exploring the possibilities of using various radio-sensitizers; these nanoscale entities focus the destructive effects of radiotherapy more specifically on tumour cells. [More]
Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions